|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00314 SIPAI HEALTH
Nominal 
5.500 +0.120 (+2.230%) | 2024/06 - Interim RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | (133,495) | (182,066) | (621,919) | (192,117) |
| Net Cash from / (used in) Investing Activities | -- | (720,809) | 1,029,771 | (1,020,333) | 319,617 |
| Net Cash from / (used in) Financing Activities | -- | (120,548) | 81,690 | 559,292 | 1,311,939 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (974,852) | 929,395 | (1,082,960) | 1,439,439 |
| Cash & Cash Equivalents at beginning of period | -- | 1,455,454 | 535,849 | 1,628,021 | 199,110 |
| Effect of Foreign Exchange Rate Changes | -- | 14,823 | (9,790) | (9,212) | (10,528) |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 495,425 | 1,455,454 | 535,849 | 1,628,021 |
| Remarks: | Real time quote last updated: 27/12/2024 15:01 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -78,202 |
| %Change | -15.293% |
| EPS / (LPS) | RMB -0.120 |
| NBV Per Share (¥) | RMB 1.962 |